<SEC-DOCUMENT>0001213900-23-009318-index.html : 20230208
<SEC-HEADER>0001213900-23-009318.hdr.sgml : 20230208
<ACCEPTANCE-DATETIME>20230208170009
ACCESSION NUMBER:		0001213900-23-009318
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230208
DATE AS OF CHANGE:		20230208
GROUP MEMBERS:		AISLING CAPITAL PARTNERS IV LLC
GROUP MEMBERS:		AISLING CAPITAL PARTNERS IV, LP
GROUP MEMBERS:		ANDREW N. SCHIFF
GROUP MEMBERS:		STEVE ELMS

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Elevation Oncology, Inc.
		CENTRAL INDEX KEY:			0001783032
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				841771427
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92657
		FILM NUMBER:		23599893

	BUSINESS ADDRESS:	
		STREET 1:		888 SEVENTH AVE
		STREET 2:		12TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10106
		BUSINESS PHONE:		212-651-6380

	MAIL ADDRESS:	
		STREET 1:		888 SEVENTH AVE
		STREET 2:		12TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10106

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	14ner Oncology, Inc.
		DATE OF NAME CHANGE:	20190719

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aisling Capital IV, LP
		CENTRAL INDEX KEY:			0001652910
		IRS NUMBER:				474953768
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		888 SEVENTH AVENUE, 12TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10106
		BUSINESS PHONE:		212-651-6380

	MAIL ADDRESS:	
		STREET 1:		888 SEVENTH AVENUE, 12TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10106
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>ea172925-13ga1aisling4_eleva.htm
<DESCRIPTION>AMENDMENT NO. 1 TO SCHEDULE 13G
<TEXT>
Document 1 - file: ea172925-13ga1aisling4_eleva.htm

</DOCUMENT>
</SEC-DOCUMENT>